These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19858133)

  • 1. Strategies to screen and reduce vascular risk--putting statins in the tap water is not the answer.
    Zaman MJ; Jones MM
    Heart; 2010 Feb; 96(3):177-8. PubMed ID: 19858133
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-cost strategies to predict cardiovascular disease.
    Wilson PW; Narayan KM
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):518-9. PubMed ID: 18628774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detecting risk factors in cardiology].
    Manus JM
    Rev Infirm; 2000 Mar; (58):45-6. PubMed ID: 11075165
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and management of the workplace for CVD risk.
    Nowack KM; Schnall P; Melamed S; Froom P; Fisher J; Belkić K
    Occup Med; 2000; 15(1):231-56. PubMed ID: 10702088
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 6. How to screen athletes for cardiovascular diseases.
    Corrado D; Michieli P; Basso C; Schiavon M; Thiene G
    Cardiol Clin; 2007 Aug; 25(3):391-7, v-vi. PubMed ID: 17961793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design for a cardiovascular screening and prevention study with tele-cardiology in Mediterranean Italy: the CAPITAL study (CArdiovascular Prevention wIth Telecardiology in ApuLia).
    Brunetti ND; De Gennaro L; Dellegrottaglie G; Straziota E; Novielli V; Antonelli G; Di Biase M
    Int J Cardiol; 2011 May; 149(1):130-3. PubMed ID: 21396730
    [No Abstract]   [Full Text] [Related]  

  • 8. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cardiovascular disease: concerns with a Norwegian proposal.
    Simmonds MC; Wald N
    J Med Screen; 2011; 18(4):165-6. PubMed ID: 22184731
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and molecular markers for vascular disease. Overview.
    Ballantyne CM
    J Cardiovasc Risk; 1997; 4(5-6):321-3. PubMed ID: 9865661
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 3921 people.
    Lawson KD; Fenwick EA; Pell AC; Pell JP
    Heart; 2010 Feb; 96(3):208-12. PubMed ID: 19737737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identify and treat subjects at high cardiovascular risk should be a priority!].
    Simon A
    Rev Prat; 2012 Jun; 62(6):769-70. PubMed ID: 22838266
    [No Abstract]   [Full Text] [Related]  

  • 13. A better way to screen for cardiovascular disease?
    Kotz D
    US News World Rep; 2008 Nov 17-24; 145(11):80, 82. PubMed ID: 19130761
    [No Abstract]   [Full Text] [Related]  

  • 14. New screening procedure signals risk of CVD at earlier stage.
    Dis Manag Advis; 2001 Nov; 7(11):166-9, 161. PubMed ID: 11759311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the prevention and treatment of cardiovascular disease.
    Weisfeldt ML; Zieman SJ
    Health Aff (Millwood); 2007; 26(1):25-37. PubMed ID: 17211011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referrals to dietitians after cardiovascular screening program held in supermarket.
    Strychar IM; Potvin L; Pineault R; Pineau R; Prévost D
    J Am Diet Assoc; 1995 Jul; 95(7):806-8. PubMed ID: 7797815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of cardiovascular diseases: collaborative program].
    Vértes A; Gyárfás I; Ofner P
    Orv Hetil; 2006 Oct; 147(39):1867-73. PubMed ID: 17111648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular evaluation of the worker and workplace: a practical guide for clinicians.
    Belkić K; Schnall P; Ugljesić M
    Occup Med; 2000; 15(1):213-22, iv. PubMed ID: 10702086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hospital-wide vascular screening program at the University Medical Center, Utrecht: prevalence of risk factors and asymptomatic vascular disease from 1996 to 2002].
    Visseren FL; de Jaegere PP; Banga JD; Kappelle LJ; Eikelboom BC; Mali WP; Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2376-82. PubMed ID: 14677480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of individual cardiovascular risk in a primary prevention setting shows a high number of patients with a high risk score.
    Neuss M; Roser M; Kelle S; Girke F; Winbeck G; Stawowy P; Fleck E
    Z Kardiol; 2004 May; 93(5):413-5. PubMed ID: 15160278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.